resistance and its compensatory hyperinsulinemia, and studies have documented a linkage between insulin resistance and cardiovascular diseases (CVD) [3] [4] [5] . The World Health Organization first defined MS in 1999 6) , which was followed by the Third Report of National Cholesterol Education Program's Adult Treatment Panel (ATP ) in 2001 7) . Despite extensive research efforts on MS, the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) mutually stated that all individual CVD risk factors should be carefully treated irrespective of MS until more critical information on MS is available 8) . Nevertheless, the statements of American Heart Association and the National Heart Lung Blood Institute disagreed with the ADA/EASD statement
Introduction
The phenomenon of multiple cardiovascular risk factor clustering has been noted for decades 1) , but received little attention until Reaven described "syndrome X" in 1988 2) . Increasingly, "syndrome X" became interchangeable with "insulin resistance syndrome" or "metabolic syndrome" (MS), the most commonly used term to date. Syndrome X is characterized by insulin and strengthened the importance of MS 9) . In spite of the abovementioned controversies, the ultimate purpose of defining MS is to identify people who are at a higher risk of developing type 2 diabetes mellitus (DM) and CVD 10) . In terms of predicting DM, MS has been proved to be a good predictor of type 2 DM [11] [12] [13] [14] [15] [16] , but some contradictory reports have challenged the effectiveness of MS to fulfill this role 17, 18) . A recent report indicated that MS did not predict NOD in a middle-aged Chinese population 18) ; however, the effectiveness of MS to predict NOD in older adults remains uncertain. The clinical significance of DM onset at later age has been challenged 19) ; therefore, using a diagnosis of MS to predict NOD in the elderly population may be logically problematic. In spite of the aforementioned challenges, MS is reported to be closely associated with coronary artery disease and cerebrovascular events in elderly Turks, which supported the benefits of diagnosing MS in older adults 20) . Therefore, the main purpose of this study was to evaluate the effectiveness of MS in DM prediction among community-living older Taiwanese.
Methods

Subjects
In 2000, a community study focusing on individuals aged over 40 in 3 townships (Tou-Cheng, Tonshan, Shanhsing) of I-Lan County in Taiwan was conducted to explore the metabolic characteristics of insulin resistance [21] [22] [23] . Residents participating in the annual health examinations held by the Bureau of National Health Insurance were recruited after they were fully consented. Subjects with DM and those who were receiving anti-hypertensive treatment were excluded from further analysis. The study was approved by the ethics committee of Taipei Veterans General Hospital. In 2005, subjects recruited from Tou-Cheng Township were invited for a follow-up study.
Demographic and Physical Examinations
Experienced research staff recorded each subject's age, sex, and we measured each subject's height and weight to calculate the body mass index (BMI). Obesity and central obesity were defined by the Recommendations of the International Obesity Task Force 24) . In 2000, the Taiwanese official definition of obesity required no measurements of waist circumference. Personal medical history was also recorded in detail but the family history of DM was not obtained because of the inability of participants to recall their parents' DM status. Blood pressure was measured according to the sixth report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure 25) .
Laboratory Examinations
All subjects underwent blood testing after a 10-h overnight fast to measure serum levels of glucose, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C) using an automatic analyzer (Model 736; Hitachi, Tokyo, Japan), and fasting insulin (FI) was measured by radioimmunoassay (Diagnostic Product Corporation, CA, USA).
Diagnosis of Diabetes and Metabolic Syndrome
The diagnosis of DM was made using the ADA criteria in 2001 26) , and the diagnosis of MS by the ATP definition 7) , which was modified in this study, including lower fasting plasma glucose of 100 mg/dL by ADA recommendations, and waist circumference was replaced by BMI ≥ 27 kg/m 2 , as previously reported in Taiwanese 27, 28) . NOD was defined as those who were DM-free in 2000 and became DM in 2005 (including plasma glucose re-testing and current antihyperglycemic agent usage).
Insulin Resistance
Insulin resistance was expressed by the Homeostasis Model Assessment (HOMA), in which HOMA-IR was calculated by multiplying FPG (in mmole/L) by FI (in mU/L), and dividing the result by 22.5 29) . The cutoff for HOMA-IR to determine insulin resistance for all subjects was defined as the highest quartile of HOMA-IR among lean subjects (BMI 25 kg/m 2 ), and subjects with a higher HOMA-IR were considered insulin resistant 30) .
Effectiveness of NOD Prediction
The effectiveness of NOD prediction is evaluated by the positive predictive value of IFG and MS in predicting NOD. The positive predictive value is usually defined as (number of true positives) / (number of true positives number of false positives); therefore, the positive predictive value of MS is defined as the number of NOD in MS ( ) subjects in 2005 divided by all MS subjects in 2000. The positive predictive value of IFG is defined as the number of NOD in IFG ( ) subjects in 2005 divided by all IFG subjects in 2000.
Data Analysis
Data in the text and tables are expressed as the mean standard deviation (mean SD). Groups with subjects with and without MS were composed with the Chi square test, Fisher's Exact test, or Student's t -test when appropriate (SPSS 13.0; Chicago, IL, USA). Adjusted for age and gender, logistic regression is used to determine whether MS can predict NOD. Moreover, all five diagnostic components were input to determine the individual role of all 5 diagnostic components of MS in predicting NOD. For all tests, p 0.05 (two-tailed) was considered significant.
Results
Demography
Overall, 721 subjects who participated the community survey in 2000 were successfully followed in 2005. Among them, 96 were diabetic in 2000 (with or without treatment), 88 were currently taking antihypertensive agents, and 57 had died of various etiologies. Due to the lack of precise death statistics, subjects who died within the study period were excluded from further analysis. After exclusion of aforementioned subjects, 480 non-diabetic and anti-hypertensive agent-free subjects were the primary cohort for study (mean age: 63.7 10.8 years in 2000, 43.8% males).
Metabolic Syndrome
The overall prevalence of MS was 25.4%. The mean age and gender distributions in MS and non-MS subjects were similar (64.1 10.1 vs. 63.5 11.1 years, p 0.598; 59.8% females vs. 55.0% females, p 0.398). Compared with non-MS subjects, MS subjects had significantly higher BMI, mean systolic blood pressure, diastolic blood pressure, and pulse pressure. Moreover, MS subjects were more prone to be obese, hypertensive and insulin resistant (defined by HOMA-IR higher than 1.23). In laboratory results, MS subjects had higher fasting plasma glucose, serum levels of TC, TG and lower HDL-C ( Table 1) .
New-Onset DM
The 5-year cumulative incidence of NOD in this study was 10.8%, which was significantly higher in the MS group than the non-MS group (17.2% vs. 8.7%, p 0.011). Adjusted for age and gender, MS significantly predicts NOD in this study (Odds ratio: 2.20, 95% Confidence interval: 1.21 − 4.00, p 0.010). Moreover, both impaired fasting glucose (IFG) and hypertriglyceridemia were significant risk factors for NOD among all 5 diagnostic components of MS ( Table 2 ). The positive predictive value of IFG for NOD was better than MS (42.9% for IFG and 17.2% for MS).
Discussion
Impaired carbohydrate homeostasis in older adults is a well-known age-related phenomenon 31) . Along with advancing age, fasting and postload plasma glucose levels were slightly but significantly increased [32] [33] [34] . Despite these age-related phenomena in glucose metabolism, there are no age-adjusted criteria for DM diagnosis in older people. Based on current diagnostic criteria, the epidemiology of DM in the elderly popu- , hypertension was defined according to the JNC 6 report, and insulin resistance was defined when HOMA-IR 1.23. HDL-C: high density lipoprotein-cholesterol. lation remains unclear 35) , and it is suggested that approximately 20% of people aged 75 and over were diabetic 36) . Although many previous reports supported the ability of MS to predict DM, little is known in the elderly Chinese population. In this study, we confirmed that MS may significantly predict NOD in older Taiwanese in a 5-year period. To our knowledge, this is the first study confirmed the effectiveness of MS to predict DM in older Taiwanese.
Defining DM in older adults is a complex issue, especially when DM onset in later life showed no association with mortality in men 18) ; therefore, the necessity of defining MS in the elderly population deserves further investigation. Whether the central etiological factor of MS is insulin resistance or central obesity is under debate, although the International Diabetes Federation favors the role of central obesity. It is well known that aging is featured by progressive loss of lean body mass and increased waist circumference; therefore, adverse effects derived from these agerelated anthropometric changes may also increase the probability of central obesity and insulin resistance. Overall, older adults are naturally more prone to be diabetic with or without MS. The report of ADA/ EASD has indicated that pre-diabetes is a more powerful predictive factor for NOD than MS, which was also confirmed in this study and its effectiveness successfully extended into older age.
Nevertheless, there are several limitations of this study. First, subjects were enrolled from participants in community health examinations instead of a systemic sampling; however, from the perspective of community health, staff of all community-based health clinics had invited all eligible residents in their townships to participate in the health examinations; therefore, we believe that the study cohort is representative enough for the whole community. Second, this study adopted ADA criteria for DM diagnosis, which needs no glucose loading test. The vast majority of study participants were farmers in rural communities, and they mostly refused oral glucose tolerance tests because they need to go to their farms in the early morning. The primary purpose of the ADA criteria is to enhance community-based screening programs and diagnosis; therefore, we believe that the study results still provide certain important information for community healthcare professionals. Third, this study modified the ATP-criteria for MS, in which waist circumference was replaced by BMI. In 2000, the official diagnostic criteria for obesity included BMI, and similar modifications have been made in other reports 26, 27) ; therefore, we also believe this modified ATP-criterion still defined MS well. In conclusion, both MS and IFG can effectively predict NOD among community-living older Taiwanese in 5-year follow-up. Adjusted for age and gender, IFG and hypertriglyceridemia were both independent risk factors for NOD among the 5 diagnostic components of MS. In terms of predicting NOD for older people, IFG may be a more efficient predictor than MS due to the higher positive predictive value and lower laboratory cost. Insulin resistance was defined as HOMA-IR 1.23, high blood pressure was defined as systolic blood pressure 130 or diastolic blood pressure 85 mmHg, raised fasting glucose was defined as fasting plasma glucose levels 100 mg/dL, low high density lipoprotein-cholesterol (HDL-C) was defined as HDL-C 40 mg/dL in men and 50 mg/dL in women, high triglyceride (TG) was defined as serum TG 150 mg/dL, and obesity was defined as BMI 25 kg/m 2 . MS: metabolic syndrome.
